SeahLimMD

Oncology • Syracuse, NY

Physician

Join to view full profile

Dr. Lim is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lim's full profile

Already have an account?

Office
750 E Adams St
Syracuse, NY 13210
Phone+1 315-464-8200

Education & Training

University of Aberdeen Faculty of MedicineClass of 1984

Certifications & Licensure

AL State Medical License 1999 - Present
NY State Medical License 2000 - 2025
MI State Medical License 2016 - 2023
PA State Medical License 2014 - 2022
NJ State Medical License 2016 - 2021
TX State Medical License 2005 - 2021
MO State Medical License 2015 - 2019
OK State Medical License 2014 - 2018
RI State Medical License 2016 - 2018
AR State Medical License 2000 - 2001
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Join now to see all

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
Recruiting
Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match Start of enrollment: 2011 Nov 01
Terminated
Phase 2
Immuno-ablation With Chemoimmunoradiation and Autologous Stem Cell Transplant for Churg-Strauss Syndrome Start of enrollment: 2016 Apr 01
Terminated
Early Phase 1
Rifaximin to Modify the Disease Course in Sickle Cell Disease Start of enrollment: 2018 Aug 22
Unknown status
Phase 2
Join now to see all

Publications & Presentations

PubMed

Endari treatment ameliorates sickle cell-related disruption in intestinal barrier functions and is associated with prolonged survival in sickle cell mice.
Elio Haroun, Seah H Lim, Dibyendu Dutta
Hematology. 2024-12-01
GBT1118, a Voxelotor Analog, Ameliorates Hepatopathy in Sickle Cell Disease.
Elio Haroun, Seah H Lim, Dibyendu Dutta
Medicina. 2024-09-26
2 citations
Antibody-drug conjugates: Principles and opportunities.
Zhi Xin Phuna, Prashanth Ashok Kumar, Elio Haroun, Dibyendu Dutta, Seah H Lim
Life Sciences. 2024-06-15

Abstracts/Posters

Effects of Rifaximin on Intestinal Pathophysiologic Changes Associated with Sickle Cell Disease (SCD)
Seah H Lim, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

Low Incidence of Hospital-Onset Clostridium Difficile Infection in Sickle Cell DiseaseFebruary 28th, 2019
Opening EditorialFebruary 1st, 2017